Pharmacology
Co-dergocrine Mesylate enhances mental abilities and lengthens the period of intense mental workload by improving (and indeed stabilizing) oxygen supply to the brain. Furthermore, Co-dergocrine Mesylate has been shown to protect the brain and the heart from free radical damage and can improve the number and ability of brain dendrites to connect, and therefor has even been cited as ana intelligence improver.
Indications:
Dementia symptoms and complaints caused by reduced mental capacity related to old age: concentration disorder and impaired memory.
Contraindication: Know hypersentivity to Co-dergocrine Mesylate, acute and chronic psychosis.
Dosage: daily before breakfast, The gradually reduction of symptoms usually shown after 3-4 weeks treatment.
Warning and Precautions: Caution is required in the presence of severe bradycardia. Blood pressure should be checked following parenteral administration as a drop in blood pressure may occur.
Adverse Reactions: Nasal stuffiness, transient nausea and gastric upset may occur occasionally, but are usually prevented by taking Co-dergocrine Mesylate with food.
